Byondis Appoints Louis Denis, M.D., as Chief Medical Officer
NIJMEGEN, The Netherlands–(BUSINESS WIRE)– Byondis B.V., an independent clinical stage biopharmaceutical company creating innovative targeted medicines for patients with cancer, announces the appointment of Louis...